{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:55:53Z","timestamp":1785858953952,"version":"3.56.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1097\/01.coc.0000159554.97885.88","type":"journal-article","created":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T14:41:37Z","timestamp":1122907297000},"page":"379-384","source":"Crossref","is-referenced-by-count":51,"title":["Prevention of Hepatitis B Virus Reactivation in Patients With Nasopharyngeal Carcinoma With Lamivudine"],"prefix":"10.1097","volume":"28","author":[{"given":"Winnie","family":"Yeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin P.","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony T. C.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wing M.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok C.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul K. S.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony S. K.","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jam J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frankie K. F.","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-10-20210128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0360-3016(78)90137-2","article-title":"An epidemiologic and clinical study of nasopharyngeal carcinoma.","volume":"4","author":"Ho","year":"1978","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R2-10-20210128","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0360-3016(96)00323-9","article-title":"Significant prognosticators after primary radiotherapy in 903 non-disseminated nasopharyngeal carcinoma evaluated by computer tomography.","volume":"36","author":"Teo","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R3-10-20210128","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/annonc\/mdf179","article-title":"Nasopharyngeal carcinoma.","volume":"13","author":"Chan","year":"2002","journal-title":"Ann Oncol"},{"key":"R4-10-20210128","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1003::AID-CNCR1>3.0.CO;2-F","article-title":"The role of chemotherapy in the management of nasopharyngeal carcinoma.","volume":"82","author":"Chan","year":"1998","journal-title":"Cancer"},{"key":"R5-10-20210128","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1200\/JCO.2002.08.149","article-title":"Concurrent chemotherapy\u2013radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial.","volume":"20","author":"Chan","year":"2002","journal-title":"J Clin Oncol"},{"key":"R6-10-20210128","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0167-8140(02)00003-8","article-title":"Acute toxicity of adjuvant doxorubicin and cyclophosphamide for early breast cancer\u2014a retrospective review of Chinese patients and comparison with a historic Western series.","volume":"62","author":"Ma","year":"2002","journal-title":"Radiother Oncol"},{"key":"R7-10-20210128","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1056\/NEJM199712113372406","article-title":"Hepatitis B infection.","volume":"337","author":"Lee","year":"1997","journal-title":"N Engl J Med"},{"key":"R8-10-20210128","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/oxfordjournals.aje.a114681","article-title":"Hepatitis B virus infection in Chinese families in Hong Kong.","volume":"126","author":"Lok","year":"1987","journal-title":"Am J Epidemiol"},{"key":"R9-10-20210128","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1096-9071(200011)62:3<299::AID-JMV1>3.0.CO;2-0","article-title":"Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors.","volume":"62","author":"Yeo","year":"2000","journal-title":"J Med Virol"},{"key":"R10-10-20210128","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0140-6736(75)90897-1","article-title":"Fulminating hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy.","volume":"2","author":"Galbraith","year":"1975","journal-title":"Lancet"},{"key":"R11-10-20210128","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/0016-5085(91)90599-G","article-title":"Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study.","volume":"100","author":"Lok","year":"1991","journal-title":"Gastroenterology"},{"key":"R12-10-20210128","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2210::AID-CNCR24>3.0.CO;2-0","article-title":"Severe hepatitis related to chemotherapy in hepatitis B virus carriers with hematologic malignancies. Survey in Japan, 1987\u20131991.","volume":"78","author":"Nokamura","year":"1996","journal-title":"Cancer"},{"key":"R13-10-20210128","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/annonc\/8.suppl_1.S107","article-title":"Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan.","volume":"8","author":"Kumagai","year":"1997","journal-title":"Ann Oncol"},{"key":"R14-10-20210128","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1002\/cncr.10995","article-title":"Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.","volume":"95","author":"Ma","year":"2002","journal-title":"Cancer"},{"key":"R15-10-20210128","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0360-3016(99)00210-2","article-title":"Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: toxicities and preliminary results.","volume":"45","author":"Tan","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-10-20210128","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1200\/JCO.1998.16.7.2514","article-title":"Phase I\/II study of the CAPABLE regimen for patients with poorly differentiated carcinoma of the nasopharynx.","volume":"16","author":"Siu","year":"1998","journal-title":"J Clin Oncol"},{"key":"R17-10-20210128","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmv.10430","article-title":"Hepatitis B virus reactivation in breast cancer patients undergoing cytotoxic chemotherapy: a prospective study.","volume":"70","author":"Yeo","year":"2003","journal-title":"J Med Virol"},{"key":"R18-10-20210128","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/sj.bjc.6601699","article-title":"Comprehensive analysis of risk factors associating with hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy.","volume":"90","author":"Yeo","year":"2004","journal-title":"Br J Cancer"},{"key":"R19-10-20210128","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1046\/j.1365-2141.2000.01847.x","article-title":"Lamivudine allows completion of chemotherapy in lymphoma patients with hepatitis B reactivation.","volume":"108","author":"Silvestri","year":"2000","journal-title":"Br J Haematol"},{"key":"R20-10-20210128","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1182\/blood.V99.2.724","article-title":"Efficacy of lamivudine to prevent hepatitis reactivation in hepatitis B virus-infected patients treated for non-Hodgkin lymphoma.","volume":"99","author":"Persico","year":"2002","journal-title":"Blood"},{"key":"R21-10-20210128","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V100.2.391","article-title":"Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers.","volume":"100","author":"Shibolet","year":"2002","journal-title":"Blood"},{"key":"R22-10-20210128","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1365-2141.2001.03099.x","article-title":"Primary prophylaxis with lamivudine of hepatitis B virus reactivation in chronic HBsAg carriers with lymphoid malignancies treated with chemotherapy.","volume":"115","author":"Rossi","year":"2001","journal-title":"Br J Haematol"},{"key":"R23-10-20210128","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1023\/A:1026622807373","article-title":"Recovery from life-threatening corticosteroid-unresponsive, chemotherapy-related reactivation of hepatitis B associated with lamivudine therapy.","volume":"43","author":"Borg","year":"1998","journal-title":"Dig Dis Sci"},{"key":"R24-10-20210128","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1023\/A:1008206519571","article-title":"Successful treatment of lamivudine for fulminant hepatitis B infection following intensive therapy for high grade non-Hodgkin's lymphoma.","volume":"9","author":"Clark","year":"1998","journal-title":"Ann Oncol"},{"key":"R25-10-20210128","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<263::AID-JMV1>3.0.CO;2-X","article-title":"Lamivudine in the treatment of hepatitis B virus reactivation during cytotoxic chemotherapy.","volume":"59","author":"Yeo","year":"1999","journal-title":"J Med Virol"},{"key":"R26-10-20210128","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1572-0241.1999.00808.x","article-title":"Lamivudine therapy in chemotherapy-induced reactivation of hepatitis B virus infection.","volume":"94","author":"Ahmed","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R27-10-20210128","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1572-0241.2001.03824.x","article-title":"Failure of lamivudine therapy for chemotherapy-induced reactivation of hepatitis B.","volume":"96","author":"Cainelli","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R28-10-20210128","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jmv.2060","article-title":"Hepatitis B virus reactivation during cytotoxic chemotherapy-enhanced viral replication precedes overt hepatitis.","volume":"65","author":"Yeo","year":"2001","journal-title":"J Med Virol"},{"key":"R29-10-20210128","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1200\/JCO.2004.05.161","article-title":"Lamivudine for the prevention of hepatitis B virus reactivation in HBsAg seropositive cancer patients undergoing cytotoxic chemotherapy.","volume":"22","author":"Yeo","year":"2004","journal-title":"J Clin Oncol"},{"key":"R30-10-20210128","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1093\/annonc\/mdh430","article-title":"Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy.","volume":"15","author":"Yeo","year":"2004","journal-title":"Ann Oncol"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.coc.0000159554.97885.88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T14:58:44Z","timestamp":1785855524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200508000-00010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000159554.97885.88","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}